Edition:
United States

Cardinal Health Inc (CAH.N)

CAH.N on New York Stock Exchange

82.49USD
27 Feb 2017
Change (% chg)

$0.35 (+0.43%)
Prev Close
$82.14
Open
$82.14
Day's High
$82.61
Day's Low
$81.91
Volume
445,778
Avg. Vol
779,002
52-wk High
$87.85
52-wk Low
$62.80

CAH.N

Chart for CAH.N

About

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $26,021.86
Shares Outstanding(Mil.): 315.45
Dividend: 0.45
Yield (%): 2.18

Financials

  CAH.N Industry Sector
P/E (TTM): 19.84 19.06 40.61
EPS (TTM): 4.16 -- --
ROI: 9.55 11.81 59.73
ROE: 20.73 13.36 67.44

BRIEF-Cardinal Health files for potential mixed shelf, size undisclosed - SEC filing

* Files for potential mixed shelf, size undisclosed - SEC filing Source text for Eikon: (http://bit.ly/2lnvjol) Further company coverage:

Feb 07 2017

Cardinal Health revenue misses on generic drug pricing pressure

Drug distributor Cardinal Health Inc reported lower-than-expected quarterly revenue on Tuesday, hurt in part by pricing pressure for generic drugs, and cut its full-year adjusted earnings forecast for the second straight quarter.

Feb 07 2017

CORRECTED-UPDATE 2-Cardinal Health revenue misses on generic drug pricing pressure

Feb 7 Drug distributor Cardinal Health Inc reported lower-than-expected quarterly revenue on Tuesday, hurt in part by pricing pressure for generic drugs, and cut its full-year adjusted earnings forecast for the second straight quarter.

Feb 07 2017

UPDATE 3-Cardinal Health profit beats estimates on lower costs

Feb 7 Cardinal Health Inc reported a better-than-expected quarterly profit on Tuesday helped by lower costs and tax rate even as the drug distributor faced generic pricing pressure.

Feb 07 2017

BRIEF-Cardinal Health reports Q2 EPS $1.02

* Second-quarter revenue for pharmaceutical segment increased 5 percent to $29.7 billion

Feb 07 2017

Cardinal Health quarterly revenue rises about 5 percent

Feb 7 Drug distributor Cardinal Health Inc reported a 5 percent rise in quarterly revenue, helped by strength in its pharmaceutical business, which more than offset generic pricing pressure.

Feb 07 2017

Cardinal Health wins $2.25 billion U.S. defense contract: Pentagon

WASHINGTON Cardinal Health 200 LLC, a unit of Cardinal Health Inc , has been awarded a $2.25 billion U.S. defense contract to provide worldwide ordering and distribution of surgical supplies, the Pentagon said on Thursday.

Feb 02 2017

Cardinal Health wins $2.25 bln U.S. defense contract -Pentagon

WASHINGTON, Feb 2 Cardinal Health 200 LLC, a unit of Cardinal Health Inc, has been awarded a $2.25 billion U.S. defense contract to provide worldwide ordering and distribution of surgical supplies, the Pentagon said on Thursday.

Feb 02 2017

McKesson's revenue misses as pace of drug price hikes slow

Drug distributor McKesson Corp's quarterly revenue missed estimates due to slowing pace of branded drug price increases amid rising concerns over soaring prices of medicines.

Jan 25 2017

UPDATE 2-McKesson's revenue misses as pace of drug price hikes slow

Jan 25 Drug distributor McKesson Corp's quarterly revenue missed estimates due to slowing pace of branded drug price increases amid rising concerns over soaring prices of medicines.

Jan 25 2017

More From Around the Web

Competitors

Earnings vs. Estimates